← Open Payments lookup

GLORIFIN BELMONTE: Open Payments

NPI 1447346150 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,090 in 50 payments from 11 companies in 2025. Trend: 2023 $505 · 2024 $656 · 2025 $1,090

Food & beverage: $1,090
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$229
Neurocrine BioSciences, Inc.10$221
ABBVIE INC.8$154
Alkermes, Inc.8$148
Teva Pharmaceuticals USA, Inc.5$123
E.R. Squibb & Sons, L.L.C.3$62
Janssen Pharmaceuticals, Inc2$58
Lundbeck LLC1$28
Otsuka America Pharmaceutical, Inc.1$27
Vanda Pharmaceuticals Inc.1$24

Products named: CAPLYTA, INGREZZA, VRAYLAR, ARISTADA, UZEDY, COBENFY, INVEGA SUSTENNA, AUSTEDO XR.

Industry payments across HI — which companies pay providers there.